Margaret C. Fang, MD, MPH
Title
Cited by
Cited by
Year
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association …
WN Kernan, B Ovbiagele, HR Black, DM Bravata, MI Chimowitz, ...
Stroke 45 (7), 2160-2236, 2014
4990*2014
Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association
L Mosca, EJ Benjamin, K Berra, JL Bezanson, RJ Dolor, DM Lloyd-Jones, ...
Circulation 123 (11), 1243-1262, 2011
25662011
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines
DE Singer, GW Albers, JE Dalen, MC Fang, AS Go, JL Halperin, GYH Lip, ...
Chest 133 (6), 546S-592S, 2008
1876*2008
Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice …
JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ...
Chest 141 (2), e531S-e575S, 2012
11822012
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
BF Gage, C Van Walraven, L Pearce, RG Hart, PJ Koudstaal, BSP Boode, ...
Circulation 110 (16), 2287-2292, 2004
8862004
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
MC Fang, AS Go, Y Chang, LH Borowsky, NK Pomernacki, N Udaltsova, ...
Journal of the American College of Cardiology 58 (4), 395-401, 2011
8552011
The net clinical benefit of warfarin anticoagulation in atrial fibrillation
DE Singer, Y Chang, MC Fang, LH Borowsky, NK Pomernacki, ...
Annals of internal medicine 151 (5), 297-305, 2009
7472009
A pharmacogenetic versus a clinical algorithm for warfarin dosing
SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ...
New England Journal of Medicine 369 (24), 2283-2293, 2013
7422013
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
MC Fang, Y Chang, EM Hylek, J Rosand, SM Greenberg, AS Go, ...
Annals of Internal Medicine 141 (10), 745-752, 2004
6492004
Death and disability from warfarin-associated intracranial and extracranial hemorrhages
MC Fang, AS Go, Y Chang, EM Hylek, LE Henault, NG Jensvold, ...
The American journal of medicine 120 (8), 700-705, 2007
5562007
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study
MC Fang, DE Singer, Y Chang, EM Hylek, LE Henault, NG Jensvold, ...
Circulation 112 (12), 1687-1691, 2005
4992005
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
AS Go, MC Fang, N Udaltsova, Y Chang, NK Pomernacki, L Borowsky, ...
Circulation 119 (10), 1363-1369, 2009
4712009
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
MC Fang, AS Go, Y Chang, L Borowsky, NK Pomernacki, DE Singer, ...
Journal of the American College of Cardiology 51 (8), 810-815, 2008
3722008
American Heart Association Statistics C, Stroke Statistics S: Heart disease and stroke statistics--2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), e29-322, 2015
335*2015
A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score
DE Singer, Y Chang, LH Borowsky, MC Fang, NK Pomernacki, ...
Journal of the American Heart Association 2 (3), e000250, 2013
3282013
Stable nonviral genetic correction of inherited human skin disease
S Ortiz-Urda, B Thyagarajan, DR Keene, Q Lin, M Fang, MP Calos, ...
Nature medicine 8 (10), 1166-1170, 2002
3192002
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation
MC Fang, RS Stafford, JN Ruskin, DE Singer
Archives of internal medicine 164 (1), 55-60, 2004
2812004
Age and the risk of warfarin‐associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study
MC Fang, AS Go, EM Hylek, Y Chang, LE Henault, NG Jensvold, ...
Journal of the American Geriatrics Society 54 (8), 1231-1236, 2006
2772006
Warfarin discontinuation after starting warfarin for atrial fibrillation
MC Fang, AS Go, Y Chang, LH Borowsky, NK Pomernacki, N Udaltsova, ...
Circulation: Cardiovascular Quality and Outcomes 3 (6), 624-631, 2010
2282010
Health literacy and anticoagulation-related outcomes among patients taking warfarin
MC Fang, EL Machtinger, F Wang, D Schillinger
Journal of general internal medicine 21 (8), 841-846, 2006
2242006
The system can't perform the operation now. Try again later.
Articles 1–20